Waverly Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
JFG
Waverly Advisors's ARKG Position: Q2 2026 in Review
Waverly Advisors opened a new position in ARK Genomic Revolution ETF (ARKG) in Q2 2026: 6,069 shares worth $255K. The stake represents ﹤0.01% of the portfolio and ranks #1504 among its holdings. This is a return to the name: Waverly Advisors previously reported a position in ARKG as recently as Q3 2024.
Waverly Advisors first reported a position in ARKG in Q2 2019 and has held it in 23 quarters since. The position peaked at $1.66M in Q3 2021. 274 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.
- Waverly Advisors held 6,069 shares of ARK Genomic Revolution ETF worth $255K as of Q2 2026.
- ARK Genomic Revolution ETF was a new Waverly Advisors position in Q2 2026.
- ARK Genomic Revolution ETF made up ﹤0.01% of Waverly Advisors's portfolio in Q2 2026, its #1504 holding.
- Waverly Advisors first reported a position in ARK Genomic Revolution ETF in Q2 2019 and has held it in 23 quarters since.
- Waverly Advisors's ARK Genomic Revolution ETF position peaked at $1.66M in Q3 2021.
- 274 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.
Based on Waverly Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.